Background: The incidence of breast cancer is high, with serious implications in terms of lives and health. Relevant data show that there are approximately 1 million new cases of breast cancer reported annually, with a rising trend. Some patients have poor treatment effects and are prone to anxiety and other negative emotions, which affect their quality of life (QoL).
Aim: To explore the correlation between mental resilience, QoL, and anxiety in patients with breast cancer.
Methods: Using convenience sampling, 200 patients with breast cancer were selected from the First Affiliated Hospital of Hebei North University. These patients were investigated using the Conner-Davidson Resilience Scale, Self-Rating Anxiety Scale, and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire to analyze the impact of resilience in patients with breast cancer on their QoL and anxiety.
Results: The mean (SD) mental resilience score of the patients with breast cancer was 59.68 (± 9.84) points, the anxiety score was 49.87 (± 8.26) points, and the QoL score was 59.73 (± 8.29) points. Overall, they showed low mental resilience, mild anxiety, and medium QoL. Anxiety was negatively correlated with mental resilience and QoL ( = -0.275, = -0.289, < 0.05). QoL was positively correlated with mental resilience ( = 0.513, < 0.05). Anxiety was a mediating variable between mental resilience and QoL, accounting for 8.58% of the mediating effect.
Conclusion: Regarding psychological elasticity, anxiety plays an intermediary role in QoL among patients with breast cancer. Medical staff can improve patients' mental resilience by reducing their anxiety and improving their QoL.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11514564 | PMC |
http://dx.doi.org/10.5498/wjp.v14.i10.1458 | DOI Listing |
J Drug Target
January 2025
Department of Pharmacology, Orotta College of Medicine and Health Sciences, Asmara University, Asmara, P.O. Box: 10549, Eritrea; (I.P).
Mutations that overexpress the epidermal growth factor receptor (EGFR) are linked to cancers like breast (15-20%), head and neck (10-15%), colorectal (5-8%), and non-small cell lung cancer (10-50%), especially in East Asian populations. EGFR activation stimulates "RAS/RAF/MEK/ERK, PI3K/Akt, and MAPK" pathways, which enhance cell division, survival, angiogenesis, and tumor growth while inhibiting apoptosis and metastasis. Secondary mutations (e.
View Article and Find Full Text PDFDiscov Oncol
January 2025
Department of General Surgery, The Second Affiliated Hospital of the Air Force Medical University, Xi'an, 710038, China.
A common digestive system cancer with a dismal prognosis and a high death rate globally is breast cancer (BRCA). BRCA recurrence, metastasis, and medication resistance are all significantly impacted by cancer stem cells (CSCs). However, the relationship between CSCs and the tumor microenvironment in BRCA individuals remains unknown, and this information is critically needed.
View Article and Find Full Text PDFBreast Cancer Res Treat
January 2025
Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, 350001, Fujian , China.
Purpose: Age stratification influences the clinicopathological features and survival outcomes of breast cancer. We aimed to understand the effect of age on gene variants in young Chinese women with breast cancer compared with those from The Cancer Genome Atlas (TCGA).
Methods: Enrolled patients ≤ 40 years old (N = 370) underwent germline or somatic genetic testing using a 32-gene hereditary cancer panel at Fujian Union Hospital.
Breast Cancer Res Treat
January 2025
Division of Medical Oncology, Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, 8700 Beverly Blvd., Los Angeles, CA, 90048, USA.
Purpose: There is an increasing incidence of young breast cancer (YBC) patients with uncertainty surrounding the factors and patterns that are contributing.
Methods: We obtained characteristics and survival data from 206,156 YBC patients (≤ 40 years of age) diagnosed between 2005 and 2019 from the National Cancer Database (NCDB). Patients were subdivided into two comparison groups based on year of diagnosis (2005-2009, Old vs.
Adv Sci (Weinh)
January 2025
Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, 110122, China.
Hydrogen sulfide (HS)-mediated protein S-sulfhydration has been shown to play critical roles in several diseases. Tumor-associated macrophages (TAMs) are the predominant population of immune cells present within solid tumor tissues, and they function to restrict antitumor immunity. However, no previous study has investigated the role of protein S-sulfhydration in TAM reprogramming in breast cancer (BC).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!